Skip to main content
Signal8

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

$JAGXPress releaseJun 23, 2026, 9:00 AM ETRead the release

Jaguar Health submitted a New Animal Drug Application (NADA) to the FDA for full approval of crofelemer (Canalevia-CA1) to treat chemotherapy-induced diarrhea (CID) in dogs. The submission is supported by a pivotal effectiveness study where 77% of owners reported effectiveness and 40% saw complete resolution of symptoms, compared to 10.5% in untreated cases.

Key figures

Drug Name
crofelemer (Canalevia-CA1)
Phase Of Trial
pivotal effectiveness study
Dogs develop cancer stat
1 in 4
Annual dog cancer diagnoses
6 million
Owner reported effectiveness
77%
Cid complete resolution treated
40%
Cid complete resolution untreated
10.5%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.